Microglia and mast cells: two tracks on the road to neuroinflammation
about
Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolinNeurogenesis, inflammation and behaviorThe immune system and developmental programming of brain and behavior.Brain Injury and Inflammatory Response to Umbilical Cord Occlusions Is Limited With Worsening Acidosis in the Near-Term Ovine Fetus.Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity.Isoflavones inhibit poly(I:C)-induced serum, brain, and skin inflammatory mediators - relevance to chronic fatigue syndrome.Human Mas-related G protein-coupled receptors-X1 induce chemokine receptor 2 expression in rat dorsal root ganglia neurons and release of chemokine ligand 2 from the human LAD-2 mast cell linePalmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.Mast cells and neuroinflammation.Inhibition of microglial activation by elderberry extracts and its phenolic components.Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.Tuscan black kale sprout extract bioactivated with myrosinase: a novel natural product for neuroprotection by inflammatory and oxidative response during cerebral ischemia/reperfusion injury in rat.Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5.Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation.Pentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson's Disease.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?A future without chronic pain: neuroscience and clinical research.Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.SDF-1α and LPA modulate microglia potassium channels through rho gtpases to regulate cell morphology.Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain.Combining small-volume metabolomic and transcriptomic approaches for assessing brain chemistryFocal brain inflammation and autism.Mast Cells Release Chemokine CCL2 in Response to Parkinsonian Toxin 1-Methyl-4-Phenyl-Pyridinium (MPP(+))Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approachesLong-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder.Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis.Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation.In vivo Characterization of Amorphous Silicon Carbide As a Biomaterial for Chronic Neural InterfacesPost-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosisNeurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.Acute Phase Protein Lipocalin-2 Is Associated with Formalin-induced Nociception and Pathological Pain.Interleukin-1β pre-treated bone marrow stromal cells alleviate neuropathic pain through CCL7-mediated inhibition of microglial activation in the spinal cord.Brain-derived neurotrophic factor in the airways.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.The pain of tendinopathy: physiological or pathophysiological?Mast cells, glia and neuroinflammation: partners in crime?Sphingolipids and brain resident macrophages in neuroinflammation: an emerging aspect of nervous system pathology.
P2860
Q26802187-15CD579A-A745-4A5F-9661-F826ECE97CEAQ27016122-BD2DF314-CF3B-4293-BCA6-066E58542C70Q30449556-50FCD258-8EAB-4A7A-A826-438A4037E262Q31033989-745653BA-925C-45D0-9413-D307A23A6378Q33916678-C4E6B16E-D55B-42D8-867B-FC89DC10BBC0Q34537221-922B6C9B-8E70-48D5-93E8-C343F5BCE890Q34626038-A1D3F442-A207-4FE1-81CF-06F98A38FAB7Q34640959-A65D3822-C840-42F0-84A7-D2D522C5E75CQ34675135-932058FF-7002-4119-931E-5346B7D9F244Q34810678-6950CAC4-BAD7-4B9D-9050-0B6088CDA035Q35514566-2DC61A21-6C6C-415D-87C2-B506652514E2Q35746518-2324A94A-012D-4A08-BF27-BCD600F5A269Q35834600-F7D3A8F1-9DAA-4B37-8788-24D299F17D7CQ35904954-ACE196FC-D36B-48D3-BAEC-202E2B8A67CCQ36113520-B4AB747E-30DC-48C1-A99E-6C53280C5D71Q36154563-EBFB1E3B-4050-4742-A8E5-389A8376E87BQ36348374-9C2F7479-AC1C-460B-9950-1607B3AB8277Q36577074-103279ED-65BD-4F7F-A986-4C2BE0B73E54Q36616592-18D28550-D464-49E6-B6AD-5134694CEE97Q36618726-F8D5C701-0C07-43A2-B6AF-94841147CCE4Q36666708-D40626D9-E8DE-4645-96CE-A6AF931A448DQ36681040-DE08DDF4-060B-41FC-A325-259944E36DDAQ36709114-79EF6D30-0333-41FA-90A1-05C428C0FB01Q36766675-DC27E38F-6E57-4B69-96FE-2FEDE20DF812Q36805502-9B87E906-F66C-459E-A15C-C6B7DBD9DEDAQ36830938-89D414F6-6A16-4266-B445-7494B130B943Q36833660-1421C8E2-E700-4072-AD0D-56746C0C7507Q36932270-353E65B3-9094-4FF4-B695-7AA7542B14D8Q36955447-26C320D8-471E-4568-A70E-7A55E223D7CAQ37019818-8F39BE3C-39BC-4676-98D8-9BAEBE0CD5FEQ37043385-3685A84D-93AC-4A42-A9F2-3B2D7C1A8938Q37085041-CF630BB3-86D5-480E-89E1-719EC29A8FAFQ37417949-F6D6BBE8-72EC-4420-AC39-9155EDE8A5A3Q37420231-73B6A326-C1E3-4A8D-81CD-77BB4032D664Q37640194-5161FEF0-4AFE-4E90-AB81-8CA3BD19275AQ37708536-A34BE56B-CF32-48C9-974E-E8674CA69C03Q38118187-23E75909-B84D-4592-9E2D-8B54F3837459Q38136600-08D94622-90C6-4BC5-83AC-694540C08FA6Q38137173-96EAF2E2-9B40-422D-A1D9-47381E46975DQ38147080-4A4F774B-5D12-4B28-8811-0D2E3536B026
P2860
Microglia and mast cells: two tracks on the road to neuroinflammation
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Microglia and mast cells: two tracks on the road to neuroinflammation
@ast
Microglia and mast cells: two tracks on the road to neuroinflammation
@en
Microglia and mast cells: two tracks on the road to neuroinflammation
@nl
type
label
Microglia and mast cells: two tracks on the road to neuroinflammation
@ast
Microglia and mast cells: two tracks on the road to neuroinflammation
@en
Microglia and mast cells: two tracks on the road to neuroinflammation
@nl
prefLabel
Microglia and mast cells: two tracks on the road to neuroinflammation
@ast
Microglia and mast cells: two tracks on the road to neuroinflammation
@en
Microglia and mast cells: two tracks on the road to neuroinflammation
@nl
P921
P3181
P356
P1433
P1476
Microglia and mast cells: two tracks on the road to neuroinflammation
@en
P2093
Laura Facci
Stephen D Skaper
P304
P3181
P356
10.1096/FJ.11-197194
P407
P577
2012-04-19T00:00:00Z